Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens

Epstein–Barr virus (EBV) was discovered in 1964 in the cell line of Burkitt lymphoma and became first known human oncogenic virus. EBV belongs to the <i>Herpesviridae</i> family, and is present worldwide as it infects 95% of people. Infection with EBV usually happens during childhood whe...

Full description

Bibliographic Details
Main Authors:	Marija Rozman, Petra Korać, Karlo Jambrosic, Snjezana Židovec Lepej
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Pathogens
Subjects:	EBV replication cycle EBV and immune response prophylactic EBV vaccine therapeutic EBV vaccine EBV mRNA vaccine
Online Access:	https://www.mdpi.com/2076-0817/11/8/864

Similar Items

Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine
by: Henry H. Balfour, et al.
Published: (2022-08-01)

EBV-associated diseases: Current therapeutics and emerging technologies
by: Srishti Chakravorty, et al.
Published: (2022-10-01)

Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
by: Xinle Cui, et al.
Published: (2021-10-01)

miRNAs: EBV Mechanism for Escaping Host’s Immune Response and Supporting Tumorigenesis
by: Snježana Židovec Lepej, et al.
Published: (2020-05-01)

Genotypes of Epstein–Barr virus (EBV1/EBV2) in individuals with infectious mononucleosis in the metropolitan area of Belém, Brazil, between 2005 and 2016
by: Talita Antonia Furtado Monteiro, et al.
Published: (2020-07-01)

EBV DNA methylation profiles and its application in distinguishing nasopharyngeal carcinoma and nasal NK/T-cell lymphoma
by: Cao-Li Tang, et al.
Published: (2024-01-01)

A combined antibody and DNA assay for EBV infection in children
by: Yulu Yang, et al.
Published: (2022-08-01)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
by: James P. Dugan, et al.
Published: (2019-03-01)

EBV AND HIV-RELATED LYMPHOMA
by: Andrea Antinori, et al.
Published: (2009-11-01)

The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies
by: Angela Kwok-Fung Lo, et al.
Published: (2020-07-01)

EBV protection‐ and susceptibility‐related HLA alleles and EBV status in the Chinese population: A single‐center study
by: Dina Suolitiken, et al.
Published: (2022-07-01)

EBV infection in immunocompetent patient: problems and solutions in serological diagnosis
by: Massimo De Paschale, et al.
Published: (2011-09-01)

The Potential for EBV Vaccines to Prevent Multiple Sclerosis
by: Peter A. Maple, et al.
Published: (2022-06-01)

EBV-Associated Cancer and Autoimmunity: Searching for Therapies
by: Giovanni Capone, et al.
Published: (2015-02-01)

Clonal heterogeneity of polymorphic B-cell lymphoproliferative disease, EBV-positive, iatrogenic/immune senescence: implications on pathogenesis and treatment
by: Yu-Yan Hwang, et al.
Published: (2022-12-01)

Severe thrombocytopenia in primary EBV- Infection with no signs of infectious mononucleosis. A case report
by: Maria Pishmisheva-Peleva, et al.
Published: (2022-01-01)

Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
by: Yoshitaka Sato
Published: (2018-11-01)

The concentration of IL-6, TNF-α, s-ICAM-1, and EBV DNA load – predictive factors of hepatological complications in children with infectious mononucleosis. A pilot study
by: Justyna Moppert, et al.
Published: (2023-03-01)

Molecular Characterisation of Epstein–Barr Virus in Classical Hodgkin Lymphoma
by: Valerija Begić, et al.
Published: (2022-12-01)

Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis
by: Justin J. Kuhlman, et al.
Published: (2021-05-01)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
by: Wenting Li, et al.
Published: (2023-01-01)

Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer
by: Aviva Atri-Schuller, et al.
Published: (2022-11-01)

Editorial: “Encontrando a Biologia Vegetal”
by: Maria Fabíola Gomes da Silva de Barros, et al.
Published: (2018-09-01)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
by: Qiuting Zhang, et al.
Published: (2023-09-01)

Syntropy in Children with EBV Infection
by: L.A. Khodak, et al.
Published: (2015-05-01)

Detecção do vírus Epstein-Barr (EBV) em adenocarcinomas gástricos procedentes dos estados do Ceará e de São Paulo Epstein-Barr virus (EBV) detection in gastric carcinomas from Ceará and São Paulo states, in Brazil
by: Marcos Antonio Pereira de Lima, et al.
Published: (2011-04-01)

EBV and Lymphomagenesis
by: Daniel G. Sausen, et al.
Published: (2023-04-01)

The possible role of EBV in carcinogenesis of colorectal carcinoma.
by: Manal A. habib
Published: (2010-07-01)

Frequency of EBV Infection in HIV Positives Patients
by: alireza Abdollahi, et al.
Published: (2014-12-01)

A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness
by: KaMaría José Lista, et al.
Published: (2017-08-01)

Never too old: A case of fatal epstein barr virus pneumonia in an immunocompetent adult
by: Carl Tanba, et al.
Published: (2024-01-01)

Progress in EBV Vaccines
by: Dwain G. van Zyl, et al.
Published: (2019-02-01)

The Central Role of the Ubiquitin–Proteasome System in EBV-Mediated Oncogenesis
by: Yonggang Pei, et al.
Published: (2022-01-01)

Genetic Patterns Found in the Nuclear Localization Signals (NLSs) Associated with EBV-1 and EBV-2 Provide New Insights into Their Contribution to Different Cell-Type Specificities
by: Louise Zanella, et al.
Published: (2021-05-01)

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
by: Maria Grazia Rodriquenz, et al.
Published: (2020-05-01)

No detection of EBV, BKV and JCV in breast cancer tissue samples in Iran
by: Razieh Dowran, et al.
Published: (2019-03-01)

EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis
by: Mara Cirone
Published: (2018-10-01)

Stress-Induced Epstein-Barr Virus Reactivation
by: Daniel G. Sausen, et al.
Published: (2021-09-01)

Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation
by: Richard J. O’Reilly, et al.
Published: (2024-01-01)

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
by: Hironori Yoshiyama, et al.
Published: (2012-11-01)